INVO Fertility (IVF) Retained Earnings (2010 - 2026)
INVO Fertility's (IVF) quarterly Retained Earnings came in at -$96.9 million in Q1 2026, down 14.17% year-on-year from -$112.9 million in Q1 2025, and down 6.05% on a QoQ basis from -$91.4 million in Q4 2025.
INVO Fertility (IVF) Retained Earnings (2010 - 2026) Analysis & Trends
INVO Fertility (IVF) has 17 years of Retained Earnings data on file, last reported at -$96.9 million in Q1 2026.
- On a quarterly basis, Retained Earnings fell 14.17% year-over-year to -$96.9 million in Q1 2026; TTM through Mar 2026 was -$96.9 million, a 14.17% decrease from a year earlier, with the FY2025 full-year figure at -$91.4 million, down 36.04% from the prior year.
- Retained Earnings for Q1 2026 stood at -$96.9 million, down from -$91.4 million in the prior quarter.
- Over the last five years, Retained Earnings for IVF reached as high as -$41.7 million in Q1 2022 and fell as low as -$96.9 million in Q1 2026.
- Historically, Retained Earnings has averaged -$65.4 million across 5 years, with a median of -$59.4 million in 2024.
- Across the five-year window, Retained Earnings slumped 203.42% in 2022 and declined 13.37% in 2024, its largest moves.
- Year by year, Retained Earnings stood at -$49.8 million in 2022, then dropped by 16.14% to -$57.8 million in 2023, then decreased by 16.17% to -$67.2 million in 2024, then plunged by 36.04% to -$91.4 million in 2025, then slipped by 6.05% to -$96.9 million in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were -$96.9 million in Q1 2026, -$91.4 million in Q4 2025, and -$93.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | INVO Fertility | 1,108.74 | -4.90 Mn | 732,978.00 | -96.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -96.90 Mn |
| Dec 31, 2025 | -91.37 Mn |
| Sep 30, 2025 | -93.09 Mn |
| Jun 30, 2025 | -90.20 Mn |
| Mar 31, 2025 | -84.87 Mn |
| Dec 31, 2024 | -67.16 Mn |
| Sep 30, 2024 | -63.50 Mn |
| Jun 30, 2024 | -61.90 Mn |
| Mar 31, 2024 | -59.40 Mn |
| Dec 31, 2023 | -57.82 Mn |
| Sep 30, 2023 | -55.80 Mn |
| Jun 30, 2023 | -54.60 Mn |
| Mar 31, 2023 | -52.33 Mn |
| Dec 31, 2022 | -49.78 Mn |
| Sep 30, 2022 | -47.02 Mn |
| Jun 30, 2022 | -44.50 Mn |
| Mar 31, 2022 | -41.67 Mn |
| Dec 31, 2021 | -38.89 Mn |
| Sep 30, 2021 | -38.75 Mn |
| Jun 30, 2021 | -36.51 Mn |